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1. Introduction 
The overt form of camitine palmitoyltransferase 
(CPT,) in mitochondria from rat liver [ 1,2] and other 
rat tissues, including heart [3,4] is potently inhibited 
by malonyl CoA. This inhibition is competitive with 
respect to palmitoyl CoA and results in considerable 
sigmoidicity in the kinetics of CPTl with respect to 
this substrate [4,5]. These findings suggest hat CPT, 
might show regulation of an allosteric nature. One 
novel aspect of the malonyl CoA inhibitory effect is 
that it is lost, or greatly diminished when the associa- 
tion of CPT, with the mitochondrial membrane is 
disrupted [1,4]. In studies [3,5] CPT, activity was 
measured as the incorporation of [ 3H] camitine into 
palmitoylcamitine. In paralIe1 studies the enzyme was 
assayed by following the reaction of released CoASH 
with 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB). It 
was noted that the effect of malonyl CoA was con- 
siderably muted when the DTNB-linked assay was 
used. In this study therefore we have examined, using 
the [3H]carnitine-based assay, the effects of thiol- 
group protection and of DTNB upon the putative 
allosteric effect of malonyl CoA on CPT,. 
Rat liver mitochondria also appear to contain an 
overt carnitine acyltransferase activity which will use 
medium chainlength substrates [6-81. This is usually 
referred to as camitine octanoyltransferase (COT) 
and, although not well characterised, appears to be 
distinct from CPT [4,6-81. Hepatic COT activity is 
also inhibited by malonyl CoA [9], showing greater 
sensitivity to this effector than CPT1. In addition, the 
effect of malonyl CoA is noncompetitive with respect 
to octanoyl CoA and does not cause sigmoidicity in 
the kinetics with this substrate [ 51. This activity is 
also considered in this study and shown to differ 
from CPT,, in its response to DTNB and reduced glu- 
tathione (GSH). 
2. Materials and methods 
Sources of chemicals are described in [9]. In addi- 
tion, GSH was from Boehringer and DTNB from 
Sigma. Fed male Sprague-Dawley rats (160-l 80 g) 
were used throughout. Liver from a single rat or hearts 
from 4 rats were collected, finely chopped with scis- 
sors, washed to remove blood and homogenized in 
ice-cold 0.25 M sucrose containing 10 mM Tris-HCl 
(pH 7.4), 1 mM EGTA and defatted albumin 
(10 mg/ml). The volume of the homogenate was 
adjusted in the proportion 10 ml sucrose/albumin 
medium per g tissue. Centrifugation conditions for 
isolation and washing of the mitochondria were as in 
[lo]. Mitochondrial pellets were washed once with 
0.25 M sucrose/l0 mM Tris-HCl (pH 7.4)/l mM 
EGTA. Finally, the mitochondria were resuspended 
in 0.3 M sucrose/l0 mM Tris-HCl (pH 7.4)/l mM 
EGTA (2 or 4 ml medium/g original tissue for heart 
or liver mitochondria, respectively). The entire mito- 
chondrial isolation procedure was carried out at 
0-4°C and took 20-25 min. The protein contents of 
these stock mitochondrial suspensions were deter- 
mined [ 1 l] and were (mg/ml as means + SEM): liver 
4.0 + 0.2 (n = 12); heart 3.0 + 0.1 (n = 5). Enzyme 
assays were performed within 30 min of the isolation 
of mitochondria. For assay of CPT,, 50 ~1 mitochon- 
dria (200 + 8 and 150 + 6 pg protein for liver and 
heart, respectively) were preincubated at 25°C for 
2 min in 1 .O ml containing 220 mM sucrose, 40 mM 
KCl, 10 mM Tris-HCl (PH 7.4), 1 mM EGTA, defatted 
albumin (1.3 mg/ml), the indicated concentration of 
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palmitoyl CoA and other additions stated in indivld- 
ual figure legends. The reaction was initiated by addi- 
tion of 20 fl containing 0.4 I.tmol Lcarnitine and 
1 $i D,L-[methyl-3H]carnitine (Radiochemical 
Centre, Amersham). After 4 min the reaction was ter- 
minated with 1 ml ice-cold 1.2 M HCl followed by 
2 ml water-saturated butanol. After mixing and brief 
centrifugation, the butanol layer was washed with 
5 ml butanol-saturated water and 1 .O ml of the 
butanol layer, containing acyl-[ 3H] carnitine taken for 
liquid scintillation counting. The assay of covert COT 
was identical except that octanoyl CoA was used in 
place of palmitoyl CoA. Zero-time blanks were sub- 
tracted. Assays were linear with amount of mitochon- 
dria and with time over the range of acyl CoA con- 
centrations used, with and without malonyl CoA, 
with and without DTNB. Respiratory inhibitors 
(rotenone or antimycin A at 1 pg/ml) were not rou- 
tinely included in the assay mixtures since these were 
found to have no effect upon the measured rates of 
acyl carnitine formation (with or without GSH, 
DTNB or malonyl CoA). Since the mitochondria were 
coupled [4] and were incubated without phosphate, 
ADP or Mg2+ in the presence of EGTA, respiration 
was almost undetectable. Loss of the assay product 
by P-oxidation is therefore discounted. Under the 
assay conditions rates of palmitoyl CoA deacylation 
(measured as CoASH release by a sensitive recycling 
assay [ 121) were 0.8 and 0.6 nmol . mm-’ . mg pro- 
tein-’ for liver and heart mitochondria respectively 
and therefore did not significantly deplete the acyl 
CoA substrate under the assay conditions. 
3. Results and discussion 
Inclusion of 0.1 mM DTNB in CPT, assays was 
found to appreciably decrease the sensitivity to 
malonyl CoA in both liver and heart mitochondria 
(fig.1). With liver mitochondria, inclusion of 1 mM 
GSH considerably Increased the sensitivity permitting 
50% inhibition with -5 PM malonyl CoA. Similar 
sensitivity of CPTr fromlivers of fed rats was observed 
when 0.5 mM dithiothreitol (DTT) was used as the 
thiol-group protective agent [9]. As shown in [3] 
heart CPT, showed considerably greater sensitivity to 
malonyl CoA than the liver enzyme (cf. fIg.1 a,1 b). By 
contrast with liver CPT,, the sensitivity observed here 
for heart CPTi in the absence of thiol-group protecting 
agent was similar to that observed for the heart 
enzyme in the presence of 0.5 mM DDT [3]. With the 
heart enzyme the effect of DTNB can be examined 
without recourse to absurdly high malonyl CoA con- 
centrations. It may be seen (fig.1 b) that the effect of 
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Fig.1. Effect of DTNB and GSH on inhibition of CPT, by malonyl CoA. Palmitoyl CoA was present throughout at 40 PM and 
L-car&me at 400 PM; (0) with no additions; (0) with DTNB (0.1 mM); (u) with GSH (1 mM). The bars indicate SEM; where 
not shown these he within the symbol. (a) Liver mitochondria (4 expt). Absolute activities in the absence of malonyl CoA were: 
5.5 + 0.3, 7.3 f 0.2 and 5.0 f 0.2 nmol . min-’ . mg protein-‘, respectively, with no additions, DTNB or GSH. (b) Heart mito- 
chondria (3 expt). Absolute activities in the absence of malonyl CoA were: 8.4 f 0.7 and 9.2 f 0.3 nmol . min-’ . mg protein“ 
with no additions and DTNB, respectively. 
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Fig.2. Effect of DTNB concentration on liver CPT, and overt COT activities. Palmitoyl CoA and octanoyl CoA were present 
throughout at 40 nM and Lcamitine at 400 MM: (0) activity without malonyl CoA; (0) activity with malonyl CoA (SO PM for 
CPT, and 10 PM for COT assays); (m) percentage inhibition by malonyl CoA. The bars indicate SEM: (a) CPT, (3 expt); (b) overt 
COT (4 expt). 
DTNB is apparently competitive with malonyl CoA, 
simply shifting the inhibition curve by -1 order of 
magnitude. 
Fig.2 summarises an experiment in which the 
responses of CPT, and overt COT activities to DTNB 
are compared. These were found to differ consider- 
ably. DTNB increased both basal CPTr and CPTr 
activity in the presence of 50 PM malonyl CoA. This 
effect was maximal at -0.1 mM DTNB. DTNB at 
0.24 mM was sufficient to virtually abolish the effect 
of malonyl CoA under the chosen conditions (fig.2a). 
The corresponding experiment with overt COT 
(fig.2b) was performed using 10 /.LM malonyl CoA 
since liver COT is more sensitive to malonyl CoA than 
CPT, and this concentration gives near-maximal inhi- 
bition [9]. By contrast with its effect on CPTr, DTNB 
did not stimulate, but inhibited basal COT, had no 
effect on the malonyl CoA-inhibited activity and, 
even with 0.24 mM DTNB, did not achieve full aboli- 
tion of the malonyl CoA effect. 
Fig.3 shows another set of differences in the prop- 
erties of CPT, and overt COT. The effect of GSH to 
increase the percentage ffect of malonyl CoA on 
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CPT, (fig.la) is achieved by a GSH dose-dependent 
decrease in CPTr activity when malonyl CoA is 
present but with negligible change in the basal activity 
(fig.3a). By contrast, GSH decreased basal COT but 
had little effect on the malonyl CoA-inhibited activ- 
ity (fig.3b). At present no explanation is advanced for 
the effects of DTNB and GSH on COT, but the dis- 
parity in responses of CPT, and COT to these agents 
further exemplify the differences between these activ- 
ities [4,5,9] and add support to the idea that these 
may be separate enzymes. 
Liver CPT, shows sigmoidal kinetics with respect 
to palmitoyl CoA under the assay conditions employed 
here and malonyl CoA increases the sigmoidicity [5]. 
DTNB reduces the effect of the putative allosteric 
inhibitor malonyl CoA (fig.1 a) whilst increasing the 
basal activity (fig.2a) at 40 PM palmitoyl CoA, which 
is a sub-saturating concentration of this substrate 
under the assay conditions. It seemed possible that 
DTNB might be increasing this basal activity by 
decreasing the sigmoidicity of the kinetics with respect 
to palmitoyl CoA in the absence of malonyl CoA. 
This was tested for the liver (fig.4a) and the heart 
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Fig.3. Effect of GSH concentration on liver CPT, and overt COT activities. Legend as for fig.2: (a) CPT, (3 expt); (b) overt COT 
(4 expt). 
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Fig.4. Effect of DTNB on dependence of CPT, activity on palmitoyl COA concentration. LCarnitine was present throughout at 
400 PM: (0) with no additions; (0) with DTNB (0.1 mM); (m) with dithiothreitol(O.5 mM); (a) liver mitochondria (2 expt); (b) 
heart mitochondria (2 expt). 
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enzymes (fig.4b) and found to be so. The thiol-group 
protecting agent DTT had little effect whereas DTNB 
virtually abolished the sigmoidicity of the kinetics. 
With the liver enzyme DTNB decreased the Hill coef- 
ficient from 2.5-l .8. With the heart enzyme a 
decrease of 3.0-l .4 was observed. Detergent treat- 
ment has also been found to abolish sigmoidal kinetics 
of heart CF’T, [4]. 
It is concluded that thiol-group protecting agents 
do not appreciably alter the basal kinetics of CRT1 
but appear to facilitate the effect of malonyl CoA (at 
least for the liver enzyme). On the other hand, DTNB 
both diminishes the effect of malonyl CoA and alters 
the basal kinetics essentially abolishing apparent 
cooperativity with respect to palmitoyl CoA. This 
effect of DTNB is strikingly similar to that seen with 
skeletal muscle phosphofructokinase in which titra- 
tion of a single highly reactive thiol-group in the 
enzyme with DTNB abolishes sigmoidal kinetics with 
respect to fructose 6-phosphate [ 131. Further studies 
should establish whether this parallel between the 
2 enzymes is appropriate and whether membrane- 
associated CRT1 can truly be regarded as an allosteric 
enzyme in the accepted sense. 
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